Trimethoprim–sulfamethoxazole is a potentiated sulfonamide antibacterial combining inhibitors of successive folate-pathway steps. It is used extra-label in veterinary patients for selected susceptible bacterial infections and some opportunistic infections. Its clinical spectrum includes susceptible staphylococci, Enterobacterales and Nocardia, with organism- and infection-site-specific activity.
Sulfamethoxazole competes with para-aminobenzoic acid at microbial dihydropteroate synthase, reducing dihydrofolate formation. Trimethoprim inhibits dihydrofolate reductase and limits subsequent tetrahydrofolate production. Sequential blockade restricts nucleotide synthesis and can produce synergistic bactericidal activity. Susceptibility of both pathway steps and available drug exposure determine the effectiveness of the combination.
Overdose can cause CNS signs, marrow suppression and urinary crystallisation. Provide hydration and supportive care; folinic acid may be needed for severe marrow toxicity.
Co-trimoxazole oral suspension 40/200 mg per 5 mL Combined total 240 mg per 5 mL.
Oral Liquid
trimethoprim 40 mg / 5 mL + sulfamethoxazole 200 mg / 5 mL
PO
Co-trimoxazole IV concentrate 16/80 mg per mL Dilute before IV infusion: source describes 5 mL in 75-125 mL D5W over 60 minutes; inspect for crystals. Stability depends on final dilution; do not refrigerate.
Injection
trimethoprim 16 mg / mL + sulfamethoxazole 80 mg / mL
Monitor clinical response, hydration, CBC, hepatic/renal indices and tear production with prolonged treatment; thyroid tests can be reversibly depressed.
For a 1:5 trimethoprim:sulfonamide product, 30 mg/kg combined total equals 5 mg/kg trimethoprim plus 25 mg/kg sulfonamide. Never calculate the whole dose from trimethoprim concentration alone.
Oral trimethoprim absorption is poor in adult ruminants; calf data must not be generalized to adult cattle.
Multidrug protozoal regimens: canine Neospora protocols use combined TMP/sulfa 15 mg/kg PO every 12 hours for 4 weeks with clindamycin 10 mg/kg every 12 hours or pyrimethamine 1 mg/kg daily. Hepatozoon protocols use TMP/sulfa 15 mg/kg every 12 hours, pyrimethamine 0.25 mg/kg daily and clindamycin 10 mg/kg every 8 hours; courses differ by species and disease. These combinations require the complete protocol, not isolated single-drug arithmetic.